A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Safety And Efficacy Study Of Sitaxsentan Sodium In Subjects With Pulmonary Arterial Hypertension
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Safety And Efficacy Study Of Sitaxsentan Sodium In Subjects With Pulmonary Arterial Hypertension
This protocol is for subjects with pulmonary arterial hypertension and is the first of 3 studies forming the Sitaxsentan efficacy and safety trial with Randomized Prospective Assessment of Adding Sildenafil (SR-PAAS) program.
Inclusion Criteria:
Exclusion Criteria:
Bogotá, Cundinamarca, Colombia
Santo Domingo, Santo Domingo Province 4966, Dominican Republic
Hyderabad, Andhra Pradesh 500 001, India
Bangkoknoi, Bangkok 10700, Thailand
Istanbul, Fatih, 34080, Turkey (Türkiye)